Gökhan Ünver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gökhan Ünver has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Sercan Serin
Department of Obstetrics and Gynecology, Perinatology Unit Ondokuz Mayis University Faculty of Medicine Samsun Turkey
6 shared publications - Handan Çelik
Ondokuz Mayıs University, Türkiye
4 shared publications - Hüseyin Ekici
Department of Obstetrics and Gynecology, Perinatology Unit Ondokuz Mayis University Faculty of Medicine Samsun Turkey
4 shared publications - Miğraci Tosun
Ondokuz Mayıs University, Türkiye
4 shared publications - Ummet Abur
Department of Medical Genetics Ondokuz Mayis University Faculty of Medicine Samsun Turkey
3 shared publications - Engin Altundag
Department of Medical Genetics Ondokuz Mayis University Faculty of Medicine Samsun Turkey
2 shared publications
Latest Publications
- 9 November 2026
- Published by Wiley in Journal of Clinical Ultrasound
S mith– M agenis Syndrome Associated With Oropharyngeal Teratoma Detected in the Prenatal Period: A Case Report
This report presents the first prenatal diagnosis of an oropharyngeal teratoma associated with Smith–Magenis syndrome (SMS). At 21 weeks of gestation, polyhydramnios, fetal cardiac anomalies, ventriculomegaly, and an oropharyngeal mass were identified. Advanced prenatal imaging and genetic methods identified the del(17)(p11.2) microdeletion confirming the SMS diagnosis. The results obtained were further verified through postmortem fluorescence in situ hybridization (FISH) analysis. Preterm delivery occurred at 27 weeks of gestation, and histopathological examination confirmed an immature teratoma. This case highlights the importance of advanced prenatal imaging and molecular cytogenetic techniques in detecting rare microdeletion syndromes and unusual phenotypic associations, thereby expanding our understanding of the phenotypic variability of SMS.
- 9 November 2026
- Published by Wiley in Journal of Clinical Ultrasound
S mith– M agenis Syndrome Associated With Oropharyngeal Teratoma Detected in the Prenatal Period: A Case Report
This report presents the first prenatal diagnosis of an oropharyngeal teratoma associated with Smith–Magenis syndrome (SMS). At 21 weeks of gestation, polyhydramnios, fetal cardiac anomalies, ventriculomegaly, and an oropharyngeal mass were identified. Advanced prenatal imaging and genetic methods identified the del(17)(p11.2) microdeletion confirming the SMS diagnosis. The results obtained were further verified through postmortem fluorescence in situ hybridization (FISH) analysis. Preterm delivery occurred at 27 weeks of gestation, and histopathological examination confirmed an immature teratoma. This case highlights the importance of advanced prenatal imaging and molecular cytogenetic techniques in detecting rare microdeletion syndromes and unusual phenotypic associations, thereby expanding our understanding of the phenotypic variability of SMS.
- 24 September 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-7
The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction
- 24 September 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-7
The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction
- 30 August 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
PERSISTENT LEFT SUPERIOR VENA CAVA: PERINATAL OUTCOMES, CARDIAC AND GENETIC PROFILES OF ISOLATED AND NON-ISOLATED CASES
Introduction: Persistent left superior vena cava (PLSVC), the most common thoracic venous anomaly, frequently coexists with congenital defects, highlighting its clinical significance. To refine risk stratification, this study compares the prenatal sonographic profile, postnatal outcome data, and genetic associations between isolated and non-isolated PLSVC cases. Methods: This retrospective observational study included 24 fetuses prenatally diagnosed with PLSVC at a tertiary perinatology center. Cases were classified as isolated or non-isolated based on the presence of additional structural cardiac or extracardiac anomalies. Survival was defined as postnatal life until the last available follow-up; termination of pregnancy (TOP) and intrauterine fetal death (IUFD) were considered non-survival. Prenatal findings, genetic results, and perinatal outcomes were compared between the groups. Results: Of the total 24 cases, 4 were classified as isolated and 20 as non-isolated. Fetal growth restriction was observed significantly more frequently in non-isolated cases compared to isolated cases (20/20 vs. 2/4; p=0.01). The survival rate was significantly higher in isolated cases than in non-isolated cases (4/4 vs. 6/20; p=0.02). Genetic analysis was performed in nine cases. A chromosomal anomaly was detected in one case (1/9; 11.1%; trisomy 16q/monosomy 16p), which resulted in termination of pregnancy. In one other case, postnatal molecular genetic analysis revealed a pathogenic single-gene disorder (ALPL gene mutation). Conclusion: PLSVC cases diagnosed prenatally are frequently associated with additional structural anomalies and adverse perinatal outcomes, particularly in non-isolated cases. Accurate classification of accompanying anomalies and careful postnatal follow-up are of paramount importance for prognostic counseling.
- 30 August 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
PERSISTENT LEFT SUPERIOR VENA CAVA: PERINATAL OUTCOMES, CARDIAC AND GENETIC PROFILES OF ISOLATED AND NON-ISOLATED CASES
Introduction: Persistent left superior vena cava (PLSVC), the most common thoracic venous anomaly, frequently coexists with congenital defects, highlighting its clinical significance. To refine risk stratification, this study compares the prenatal sonographic profile, postnatal outcome data, and genetic associations between isolated and non-isolated PLSVC cases. Methods: This retrospective observational study included 24 fetuses prenatally diagnosed with PLSVC at a tertiary perinatology center. Cases were classified as isolated or non-isolated based on the presence of additional structural cardiac or extracardiac anomalies. Survival was defined as postnatal life until the last available follow-up; termination of pregnancy (TOP) and intrauterine fetal death (IUFD) were considered non-survival. Prenatal findings, genetic results, and perinatal outcomes were compared between the groups. Results: Of the total 24 cases, 4 were classified as isolated and 20 as non-isolated. Fetal growth restriction was observed significantly more frequently in non-isolated cases compared to isolated cases (20/20 vs. 2/4; p=0.01). The survival rate was significantly higher in isolated cases than in non-isolated cases (4/4 vs. 6/20; p=0.02). Genetic analysis was performed in nine cases. A chromosomal anomaly was detected in one case (1/9; 11.1%; trisomy 16q/monosomy 16p), which resulted in termination of pregnancy. In one other case, postnatal molecular genetic analysis revealed a pathogenic single-gene disorder (ALPL gene mutation). Conclusion: PLSVC cases diagnosed prenatally are frequently associated with additional structural anomalies and adverse perinatal outcomes, particularly in non-isolated cases. Accurate classification of accompanying anomalies and careful postnatal follow-up are of paramount importance for prognostic counseling.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Congenital pulmonary airway malformations: prenatal markers, perinatal outcomes, and long-term follow-up experience
SUMMARY OBJECTIVE: The aim of this study was to evaluate prenatal characteristics, associated anomalies, and perinatal and postnatal outcomes of fetuses diagnosed with congenital pulmonary airway malformation at a tertiary referral center. METHODS: This retrospective study analyzed data from 56 fetuses diagnosed prenatally with congenital pulmonary airway malformation by ultrasonography between January 2015 and December 2024. Maternal age, gestational age at diagnosis and delivery, lesion localization and ultrasonographic type, congenital pulmonary airway malformation volume ratio, presence of hydrops fetalis and associated anomalies, karyotype results, perinatal losses, postnatal surgical requirement, and long-term outcomes were evaluated. RESULTS: The median gestational age at diagnosis was 23 weeks (range: 15–32). Lesions were located in the right lung in 58.9% and in the left lung in 41.1% of cases. Mixed lesions were most common (44.6%), followed by microcystic (30.4%) and macrocystic (25.0%) types. Congenital pulmonary airway malformation volume ratio >1.6 was observed in 17.9% of cases, and hydrops fetalis developed in 12.5%. Associated structural anomalies were detected in 12.5% of fetuses. Pregnancy termination, intrauterine fetal demise, and neonatal death occurred in 7.1, 1.8, and 1.8% of cases, respectively. Spontaneous lesion regression was observed in 62.5% of cases, while only 12% of live-born infants required postnatal surgery. During a mean follow-up of 72.5 months (range: 22–96), no congenital pulmonary airway malformation-related mortality was observed. CONCLUSION: Most fetuses with prenatal congenital pulmonary airway malformation diagnosis have favorable perinatal and long-term outcomes. High congenital pulmonary airway malformation volume ratio and hydrops fetalis are key predictors of adverse outcomes, whereas conservative management is safe and effective in asymptomatic cases.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Open AccessCongenital pulmonary airway malformations: prenatal markers, perinatal outcomes, and long-term follow-up experience
SUMMARY OBJECTIVE: The aim of this study was to evaluate prenatal characteristics, associated anomalies, and perinatal and postnatal outcomes of fetuses diagnosed with congenital pulmonary airway malformation at a tertiary referral center. METHODS: This retrospective study analyzed data from 56 fetuses diagnosed prenatally with congenital pulmonary airway malformation by ultrasonography between January 2015 and December 2024. Maternal age, gestational age at diagnosis and delivery, lesion localization and ultrasonographic type, congenital pulmonary airway malformation volume ratio, presence of hydrops fetalis and associated anomalies, karyotype results, perinatal losses, postnatal surgical requirement, and long-term outcomes were evaluated. RESULTS: The median gestational age at diagnosis was 23 weeks (range: 15–32). Lesions were located in the right lung in 58.9% and in the left lung in 41.1% of cases. Mixed lesions were most common (44.6%), followed by microcystic (30.4%) and macrocystic (25.0%) types. Congenital pulmonary airway malformation volume ratio >1.6 was observed in 17.9% of cases, and hydrops fetalis developed in 12.5%. Associated structural anomalies were detected in 12.5% of fetuses. Pregnancy termination, intrauterine fetal demise, and neonatal death occurred in 7.1, 1.8, and 1.8% of cases, respectively. Spontaneous lesion regression was observed in 62.5% of cases, while only 12% of live-born infants required postnatal surgery. During a mean follow-up of 72.5 months (range: 22–96), no congenital pulmonary airway malformation-related mortality was observed. CONCLUSION: Most fetuses with prenatal congenital pulmonary airway malformation diagnosis have favorable perinatal and long-term outcomes. High congenital pulmonary airway malformation volume ratio and hydrops fetalis are key predictors of adverse outcomes, whereas conservative management is safe and effective in asymptomatic cases.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20252156
Prenatal diagnosis of congenital talipes equinovarus: favorable outcome is highly dependent on the absence of associated anomalies
SUMMARY OBJECTIVE: The aim of this study was to evaluate the demographic characteristics, prenatal findings, and outcomes of prenatally diagnosed congenital talipes equinovarus at a tertiary center. METHODS: A retrospective cohort study was conducted on 78 fetuses diagnosed with congenital talipes equinovarus between 2013 and 2023. Data on gestational age at diagnosis, laterality, associated anomalies, genetic results, and pregnancy outcomes were analyzed. RESULTS: The mean gestational age at diagnosis was 21±3.83 weeks. Congenital talipes equinovarus was bilateral in 60.3% of cases. Isolated congenital talipes equinovarus was present in 30.8% of cases, while 69.2% had associated anomalies, most commonly neural tube defects (32.6% of non-isolated cases). Of the 46 cases (59%) that underwent genetic analysis, 13 (28.3%) revealed abnormalities, representing 16.7% of the total cohort. Termination of pregnancy occurred in 59% of cases due to associated anomalies or genetic abnormalities. Thirty pregnancies resulted in live birth, with a prenatal diagnosis accuracy of 90%. The three false-positive cases were associated with oligohydramnios or early gestation. Postnatally, most live-born cases with confirmed congenital talipes equinovarus (77.8%) required serial casting and surgery. CONCLUSION: The prognosis for prenatally diagnosed congenital talipes equinovarus is excellent in isolated cases, supported by the absence of genetic abnormalities in this group. However, the high frequency of associated anomalies drastically alters prognosis, frequently leading to pregnancy termination and highlighting the critical need for comprehensive prenatal screening and multidisciplinary counseling.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20252156
Open AccessPrenatal diagnosis of congenital talipes equinovarus: favorable outcome is highly dependent on the absence of associated anomalies
SUMMARY OBJECTIVE: The aim of this study was to evaluate the demographic characteristics, prenatal findings, and outcomes of prenatally diagnosed congenital talipes equinovarus at a tertiary center. METHODS: A retrospective cohort study was conducted on 78 fetuses diagnosed with congenital talipes equinovarus between 2013 and 2023. Data on gestational age at diagnosis, laterality, associated anomalies, genetic results, and pregnancy outcomes were analyzed. RESULTS: The mean gestational age at diagnosis was 21±3.83 weeks. Congenital talipes equinovarus was bilateral in 60.3% of cases. Isolated congenital talipes equinovarus was present in 30.8% of cases, while 69.2% had associated anomalies, most commonly neural tube defects (32.6% of non-isolated cases). Of the 46 cases (59%) that underwent genetic analysis, 13 (28.3%) revealed abnormalities, representing 16.7% of the total cohort. Termination of pregnancy occurred in 59% of cases due to associated anomalies or genetic abnormalities. Thirty pregnancies resulted in live birth, with a prenatal diagnosis accuracy of 90%. The three false-positive cases were associated with oligohydramnios or early gestation. Postnatally, most live-born cases with confirmed congenital talipes equinovarus (77.8%) required serial casting and surgery. CONCLUSION: The prognosis for prenatally diagnosed congenital talipes equinovarus is excellent in isolated cases, supported by the absence of genetic abnormalities in this group. However, the high frequency of associated anomalies drastically alters prognosis, frequently leading to pregnancy termination and highlighting the critical need for comprehensive prenatal screening and multidisciplinary counseling.
- Open Access
- 15 May 2025
- Published by Wiley
Prenatal Diagnosis of Radial Ray Defects: Case Series and Literature Review
Objective: In this study, we aimed to present the demographic, ultrasonographic, genetic, obstetric, and postpartum results of 13 patients diagnosed with radial ray defects. Materials and methods: Thirteen patients diagnosed with radial ray defect between 2012 and 2024 were included in the study. Non-development or hypoplasia of any preaxial part of the upper extremity (radius, scaphoid, trapezoid bone, and thumb) on ultrasonography was considered a radial ray defect. Maternal age, gestational week at diagnosis, laterality of the radial ray defect, genetic results, presence of comorbid anomalies, termination status, and postpartum prognosis were obtained from the hospital records. Results: The range of maternal age at the time of diagnosis was 17-38 years and the gestational age ranged between 14-26 weeks. In the evaluation, four of the radial ray defects were bilateral, and nine were unilateral. Trisomy 18 was identified in two cases. Eight cases accepted the termination procedure. Two cases rejected termination and had spontaneous intrauterine death during pregnancy follow-up. One case was diagnosed with VACTERL association and died on postpartum 13th day. One case was monitored due to Fanconi aplastic anemia and one case had amniotic band syndrome in etiology and lives with a prosthetic arm. Conclusions: The frequency of radial ray defect accompanied by syndromic and congenital anomalies was high, and visualization of the radial bone or other preaxial bone structures on first-trimester fetal ultrasonography will ensure the diagnosis of radial ray defect in early gestational weeks. In case of a radial ray defect diagnosis, systemic organ screening should be performed with detailed ultrasonography and the necessary invasive procedure for karyotype examination should be advised to all families.
- 15 May 2025
- Published by Wiley
Open AccessPrenatal Diagnosis of Radial Ray Defects: Case Series and Literature Review
Objective: In this study, we aimed to present the demographic, ultrasonographic, genetic, obstetric, and postpartum results of 13 patients diagnosed with radial ray defects. Materials and methods: Thirteen patients diagnosed with radial ray defect between 2012 and 2024 were included in the study. Non-development or hypoplasia of any preaxial part of the upper extremity (radius, scaphoid, trapezoid bone, and thumb) on ultrasonography was considered a radial ray defect. Maternal age, gestational week at diagnosis, laterality of the radial ray defect, genetic results, presence of comorbid anomalies, termination status, and postpartum prognosis were obtained from the hospital records. Results: The range of maternal age at the time of diagnosis was 17-38 years and the gestational age ranged between 14-26 weeks. In the evaluation, four of the radial ray defects were bilateral, and nine were unilateral. Trisomy 18 was identified in two cases. Eight cases accepted the termination procedure. Two cases rejected termination and had spontaneous intrauterine death during pregnancy follow-up. One case was diagnosed with VACTERL association and died on postpartum 13th day. One case was monitored due to Fanconi aplastic anemia and one case had amniotic band syndrome in etiology and lives with a prosthetic arm. Conclusions: The frequency of radial ray defect accompanied by syndromic and congenital anomalies was high, and visualization of the radial bone or other preaxial bone structures on first-trimester fetal ultrasonography will ensure the diagnosis of radial ray defect in early gestational weeks. In case of a radial ray defect diagnosis, systemic organ screening should be performed with detailed ultrasonography and the necessary invasive procedure for karyotype examination should be advised to all families.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20251175
Prenatal diagnosis to postnatal outcomes in multicystic dysplastic kidney: experience of a tertiary center in the Black Sea region
SUMMARY OBJECTIVE: The aim of this study was to determine the association of unilateral multicystic dysplastic kidney in fetuses with genetic disorders, syndromic conditions, accompanying anatomical anomalies, and postnatal prognosis. METHODS: Cases diagnosed with multicystic dysplastic kidney and followed at the Perinatology Clinic of Samsun Ondokuz Mayıs University between January 2012 and June 2024 were retrospectively reviewed. Demographic, ultrasonographic, genetic, and postnatal outcomes were analyzed. RESULTS: Thirty-eight fetuses with multicystic dysplastic kidney were identified during intrauterine life. The diagnosis was made via antenatal ultrasonography in 97.2% of cases. Laterality was on the left side in 55.3% and on the right side in 44.7% of multicystic dysplastic kidney cases. The cohort consisted of 42.1% females and 57.9% males. Major extrarenal anomalies were present in 21.1% of fetuses with unilateral multicystic dysplastic kidney. Amniocentesis for karyotyping was performed in 23.7% of cases, all of which yielded normal karyotypes. Contralateral kidney anomalies were detected in 13.2% of cases, and ureterocele was observed in 15.8%. The most common postnatal anomalies were ureteropelvic junction obstruction and grade four-five vesicoureteral reflux. During a mean follow-up period of 7 years, no cases of hypertension or Wilms tumor were identified. CONCLUSION: Prenatal diagnosis of multicystic dysplastic kidney is crucial for early detection of potential contralateral kidney anomalies and predicting postnatal outcomes. In cases of isolated multicystic dysplastic kidney, the likelihood of karyotypic abnormalities, malignancies, or hypertension is very low, and the postnatal prognosis is favorable.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20251175
Open AccessPrenatal diagnosis to postnatal outcomes in multicystic dysplastic kidney: experience of a tertiary center in the Black Sea region
SUMMARY OBJECTIVE: The aim of this study was to determine the association of unilateral multicystic dysplastic kidney in fetuses with genetic disorders, syndromic conditions, accompanying anatomical anomalies, and postnatal prognosis. METHODS: Cases diagnosed with multicystic dysplastic kidney and followed at the Perinatology Clinic of Samsun Ondokuz Mayıs University between January 2012 and June 2024 were retrospectively reviewed. Demographic, ultrasonographic, genetic, and postnatal outcomes were analyzed. RESULTS: Thirty-eight fetuses with multicystic dysplastic kidney were identified during intrauterine life. The diagnosis was made via antenatal ultrasonography in 97.2% of cases. Laterality was on the left side in 55.3% and on the right side in 44.7% of multicystic dysplastic kidney cases. The cohort consisted of 42.1% females and 57.9% males. Major extrarenal anomalies were present in 21.1% of fetuses with unilateral multicystic dysplastic kidney. Amniocentesis for karyotyping was performed in 23.7% of cases, all of which yielded normal karyotypes. Contralateral kidney anomalies were detected in 13.2% of cases, and ureterocele was observed in 15.8%. The most common postnatal anomalies were ureteropelvic junction obstruction and grade four-five vesicoureteral reflux. During a mean follow-up period of 7 years, no cases of hypertension or Wilms tumor were identified. CONCLUSION: Prenatal diagnosis of multicystic dysplastic kidney is crucial for early detection of potential contralateral kidney anomalies and predicting postnatal outcomes. In cases of isolated multicystic dysplastic kidney, the likelihood of karyotypic abnormalities, malignancies, or hypertension is very low, and the postnatal prognosis is favorable.
- Open Access
- 1 March 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (3) , 430-433
Evaluation of first- and third-trimester afamin levels in preeclampsia
The aim of this study was to investigate serum afamin levels in the first and third trimesters in preeclampsia. Serum samples from 118 patients in the first and third trimesters were analyzed. Serum samples were collected from pregnant women who had enrolled in the first trimester. Blood was then collected from pregnant women who had developed preeclampsia and from healthy controls in the third trimester. The collected blood samples were resolved for analysis, and serum afamin concentrations were measured in the first and third trimesters. Preeclampsia and healthy controls were compared. There was no significant difference between the control and preeclampsia groups in terms of age, body mass index, and smoking. Afamin levels in the first and third trimesters were higher in the preeclampsia group than in the control group (p<0.05). In the subgroup analysis of the preeclampsia group, afamin levels were higher in the early-onset preeclampsia group than in the late-onset preeclampsia group in the first and third trimesters (p<0.05). In the receiver operating characteristic analysis afamin levels were 96.23 ng/mL in the first trimester and 123.57 ng/mL in the third trimester as cut-off values for preeclampsia. Serum afamin levels are useful for predicting preeclampsia in the first trimester in pregnant women and can be used in clinical practice as a supportive biomarker for the diagnosis of preeclampsia in the third trimester. Meta-analyzes are needed to investigate the effect of afamin levels in the prediction and diagnosis of preeclampsia and to determine the cut-off value.
- 1 March 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (3) , 430-433
Open AccessEvaluation of first- and third-trimester afamin levels in preeclampsia
The aim of this study was to investigate serum afamin levels in the first and third trimesters in preeclampsia. Serum samples from 118 patients in the first and third trimesters were analyzed. Serum samples were collected from pregnant women who had enrolled in the first trimester. Blood was then collected from pregnant women who had developed preeclampsia and from healthy controls in the third trimester. The collected blood samples were resolved for analysis, and serum afamin concentrations were measured in the first and third trimesters. Preeclampsia and healthy controls were compared. There was no significant difference between the control and preeclampsia groups in terms of age, body mass index, and smoking. Afamin levels in the first and third trimesters were higher in the preeclampsia group than in the control group (p<0.05). In the subgroup analysis of the preeclampsia group, afamin levels were higher in the early-onset preeclampsia group than in the late-onset preeclampsia group in the first and third trimesters (p<0.05). In the receiver operating characteristic analysis afamin levels were 96.23 ng/mL in the first trimester and 123.57 ng/mL in the third trimester as cut-off values for preeclampsia. Serum afamin levels are useful for predicting preeclampsia in the first trimester in pregnant women and can be used in clinical practice as a supportive biomarker for the diagnosis of preeclampsia in the third trimester. Meta-analyzes are needed to investigate the effect of afamin levels in the prediction and diagnosis of preeclampsia and to determine the cut-off value.
- 6 September 2022
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 38 (11) , 935-938
Maternal serum Sortilin-1 level as a potential biomarker for intrahepatic cholestasis of pregnancy
Objective: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease related to pregnancy in women. Sortilin-1 is a sorting receptor belonging to the vacuolar protein sorting 10 (Vps10p) domain family, and recent studies have shown that Sortilin-1 has a distinct role in the pathogenesis of biliary fibrosis and cirrhosis. We aimed to evaluate maternal serum Sortilin-1 level as a potential biomarker in pregnant women with intrahepatic cholestasis. Materials and methods: A prospective observational cohort study was conducted. We enrolled 80 pregnant women, 49 with the diagnosis of intrahepatic cholestasis of pregnancy and 31 healthy controls. Then, we measured maternal serum Sortilin-1 levels using an enzyme-linked immunosorbent assay method and compared them between groups. Results: The mean Sortilin-1 level in the ICP group was higher than control group (3.3 ± 1.7 ng/mL vs. 2.0 ± 0.6 ng/mL, respectively, p < .001). The receiver operating characteristic curve (ROC) analysis based on maternal serum Sortilin-1 levels to predict the presence of ICP was 85.3% controls [area under the curve (AUC), 0.853; 95% CI, 0.738–0.938, p < .001]. The optimal cutoff value of Sortilin-1 was 2.24 ng/mL (71.4% sensitivity and 74.2% specificity) to detect intrahepatic cholestasis of pregnancy. Conclusion: Elevated maternal serum Sortilin-1 levels are associated with ICP and can be used as a disease biomarker. Sortilin-1 levels can be combined with total bile acids, transaminases, and blood coagulation profile in the follow-up of ICP.
- 6 September 2022
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 38 (11) , 935-938
Maternal serum Sortilin-1 level as a potential biomarker for intrahepatic cholestasis of pregnancy
Objective: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease related to pregnancy in women. Sortilin-1 is a sorting receptor belonging to the vacuolar protein sorting 10 (Vps10p) domain family, and recent studies have shown that Sortilin-1 has a distinct role in the pathogenesis of biliary fibrosis and cirrhosis. We aimed to evaluate maternal serum Sortilin-1 level as a potential biomarker in pregnant women with intrahepatic cholestasis. Materials and methods: A prospective observational cohort study was conducted. We enrolled 80 pregnant women, 49 with the diagnosis of intrahepatic cholestasis of pregnancy and 31 healthy controls. Then, we measured maternal serum Sortilin-1 levels using an enzyme-linked immunosorbent assay method and compared them between groups. Results: The mean Sortilin-1 level in the ICP group was higher than control group (3.3 ± 1.7 ng/mL vs. 2.0 ± 0.6 ng/mL, respectively, p < .001). The receiver operating characteristic curve (ROC) analysis based on maternal serum Sortilin-1 levels to predict the presence of ICP was 85.3% controls [area under the curve (AUC), 0.853; 95% CI, 0.738–0.938, p < .001]. The optimal cutoff value of Sortilin-1 was 2.24 ng/mL (71.4% sensitivity and 74.2% specificity) to detect intrahepatic cholestasis of pregnancy. Conclusion: Elevated maternal serum Sortilin-1 levels are associated with ICP and can be used as a disease biomarker. Sortilin-1 levels can be combined with total bile acids, transaminases, and blood coagulation profile in the follow-up of ICP.
- 22 August 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 309 (1) , 119-126
Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levels
Purpose Zonulin has been shown to be associated with many metabolic disorders, including type 2 diabetes mellitus, metabolic syndrome, and obesity. In this study, we aimed to evaluate the association between maternal plasma zonulin levels and gestational diabetes mellitus (GDM) and its perinatal outcomes. Materials A total of 100 pregnant women, 56 with GDM and 44 controls, were included in this prospective case–control study. Maternal plasma zonulin levels were evaluated in each trimester. The association between zonulin levels and GDM, body mass index (BMI) and adverse perinatal outcomes was evaluated. The GDM predictability of zonulin levels for each trimester was analyzed with the receiver operator curve (ROC). Results Plasma zonulin levels were significantly higher in pregnant with GDM in all trimesters (p < 0.001; for all). Optimum cut-off values of plasma zonulin levels in predicting GDM: first trimester: 6.27 ng/mL, second trimester: 12.71 ng/mL, and third trimester: 18.38 ng/mL. BMI was significantly higher in pregnant women with GDM (30.5 vs 26.1; p < 0.001). Zonulin levels were significantly higher in pregnant women with GDM with overweight BMI [≥ 25–30 (kg/m2)] in all trimesters (p < 0.05; for all). Zonulin levels were significantly higher in pregnant women with composite adverse outcomes that included at least one of neonatal intensive care unit (NICU) admission, meconium-stained amniotic fluid, and 1st minute APGAR score < 7. Conclusion Increased maternal plasma zonulin levels were associated with increased risk of GDM and adverse perinatal outcomes. Zonulin may be a potential marker to predict GDM risk and perinatal outcomes.
- 22 August 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 309 (1) , 119-126
Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levels
Purpose Zonulin has been shown to be associated with many metabolic disorders, including type 2 diabetes mellitus, metabolic syndrome, and obesity. In this study, we aimed to evaluate the association between maternal plasma zonulin levels and gestational diabetes mellitus (GDM) and its perinatal outcomes. Materials A total of 100 pregnant women, 56 with GDM and 44 controls, were included in this prospective case–control study. Maternal plasma zonulin levels were evaluated in each trimester. The association between zonulin levels and GDM, body mass index (BMI) and adverse perinatal outcomes was evaluated. The GDM predictability of zonulin levels for each trimester was analyzed with the receiver operator curve (ROC). Results Plasma zonulin levels were significantly higher in pregnant with GDM in all trimesters (p < 0.001; for all). Optimum cut-off values of plasma zonulin levels in predicting GDM: first trimester: 6.27 ng/mL, second trimester: 12.71 ng/mL, and third trimester: 18.38 ng/mL. BMI was significantly higher in pregnant women with GDM (30.5 vs 26.1; p < 0.001). Zonulin levels were significantly higher in pregnant women with GDM with overweight BMI [≥ 25–30 (kg/m2)] in all trimesters (p < 0.05; for all). Zonulin levels were significantly higher in pregnant women with composite adverse outcomes that included at least one of neonatal intensive care unit (NICU) admission, meconium-stained amniotic fluid, and 1st minute APGAR score < 7. Conclusion Increased maternal plasma zonulin levels were associated with increased risk of GDM and adverse perinatal outcomes. Zonulin may be a potential marker to predict GDM risk and perinatal outcomes.